wk2- nmj, ache-i, MS modifying Flashcards

1
Q

What is the mechanism of action of succinylcholine?

A

Succinylcholine is a depolarizing neuromuscular blocker; it acts as a strong ACh receptor agonist at nicotinic receptors, causing sustained depolarization and preventing further muscle contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical uses of succinylcholine?

A

Used for rapid muscle paralysis in intubation and short surgical procedures; ideal for rapid sequence intubation due to quick onset and short duration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the adverse effects of succinylcholine?

A

Hyperkalemia (especially in burn or trauma patients)

Malignant hyperthermia (when used with halothane)

Bradycardia or arrhythmias

Post-op myalgia

fasciculations

increased intracranial/ occular/ intragastric pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism of action of rocuronium?

A

Rocuronium is a nondepolarizing neuromuscular blocker that competes with ACh for nicotinic receptors at the neuromuscular junction, preventing depolarization.
Often reversed with reversal agent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is rocuronium used for?

A

Used for muscle relaxation during surgery or mechanical ventilation; longer onset and duration than succinylcholine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of action of dantrolene?

A

Dantrolene inhibits ryanodine receptors (RyR1) in skeletal muscle, preventing Ca²⁺ release from the sarcoplasmic reticulum, thus reducing muscle contraction.

28. Trampoline: dantrolene (muscle relaxant) treats malignant hyperthermia 29. Blocking Ryan: dantrolene blocks ryanodine receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical uses of dantrolene?

A

malignant hyperthermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the moa of pyridostigmine?

A

Acetylcholinesterase inhibitor- increasing ach in synapse

5. STIGMA: “-stigmine” drug suffix of acetylcholinesterase inhibitors (e.g. pyridostigmine, neostigmine, physostigmine) 8. Community PRIDE: PYRIDOstigmine (acetylcholinesterase inhibitor used as long-term treatment for MG) 11. Quarters only: Pyridostigmine and neostigmine are quaternary amines and do not penetrate the CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

adverse effect of pyridostigmine

A

diarrhea, sweating, nausea, cramps, hypersalvation- autononic hyper activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical use of pyridostigmine

A

Myasthenia Gravis- ach increase overcome antibodies for nm receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA- glatiramer acetate

A

**Disrupsts Tcell response: **
Synthetic polymer mimicking myelin basic protein (MBP).

Acts as a decoy antigen, modulating immune response:

 Induces Th2 anti-inflammatory T cells

 Suppresses Th1 pro-inflammatory T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical Use- glatiramer acetate

A

MS disease modifying txt. Relapsing-remitting MS (RRMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

adverse effects of glatiramer acetate

A

Injection site reactions (most common)

Transient systemic symptoms after injection:

Flushing, chest pain, palpitations, anxiety (mimic MI but are benign)

No major systemic immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA of teriflunomide

A

pyrimidine synthesis inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinicl use teriflunomide

A

ms- disease modifying txt. recurring MS- syptom management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the adverse effects of teriflunomide

A

Hepatotoxicity (monitor LFTs)

Teratogenicity (Category X)

Alopecia, diarrhea, hypertension

Long half-life; may require accelerated elimination protocol (cholestyramine) if pregnancy desired

17
Q

Dimethyl Fumarate
MOA?

A

Activates Nrf2 pathway, promoting antioxidant response

Reduces oxidative stress and modulates immune system

18
Q

clincal use- dimethyl fumarate

A

Relapsing-remitting MS

19
Q

adverse effects dimethylfumarate

A

flushing, Gi symptoms

20
Q

What is the mechanism of action of fingolimod?

A

Fingolimod is a sphingosine-1-phosphate (S1P) receptor modulator that sequesters lymphocytes in lymph nodes, preventing their migration into the CNS.

21
Q

What is fingolimod used to treat?

A

Relapsing forms of multiple sclerosis (MS).

22
Q

What are the major adverse effects of fingolimod?

A

A: Bradycardia (especially after first dose), macular edema, infections, and elevated liver enzymes.

23
Q

What is the mechanism of action of cladribine?

A

A: A purine analog that inhibits DNA synthesis and repair, leading to lymphocyte depletion.

Clad in bearskins: cladribine (cytotoxic purine analog) 2. Purine shaped hammer: cladribine is a purine analog 3. Cracked replication fork: cladribine, cytarabine, and gemcitabine inhibit DNA polymerase 4. Stone Phase: antimetabolites (e.g. cladribine, cytarabine, gemcitabine) inhibit the S phase of the cell cycle (DNA synthesis) 5. Hairy caveman: cladribine treats hairy cell leukemia 6. Broken marrow: cladribine, cytarabine, and gemcitabine can cause myelosuppression 7. Immunosuppressed cane: cladribine, cytarabine, and gemcitabine can cause immunosuppression and increased risk of infection
24
Q

What is cladribine used for?

A

A: Hairy cell leukemia and relapsing forms of multiple sclerosis.

25
What is the mechanism of action of ocrelizumab?
A: Monoclonal antibody against CD20 on B cells, leading to B-cell depletion.
26
What is the mechanism of action of alemtuzumab?
A: Monoclonal antibody against CD52, causing profound lymphocyte depletion.
27
What are the key adverse effects of alemtuzumab?
A: Autoimmune diseases (e.g., thyroid disorders), infusion reactions, and increased infection risk.
28
What is the mechanism of action of natalizumab?
A: Monoclonal antibody against α4-integrin, inhibiting leukocyte adhesion and migration across the BBB.
29
What serious adverse effect is associated with natalizumab?
A: Progressive multifocal leukoencephalopathy (PML) due to JC virus reactivation.